OKYO Pharma CSO Patil Rajkumar Buys 3,363 Shares

What Happened

• Patil Rajkumar V., Chief Scientific Officer of OKYO Pharma Ltd (OKYO), reported an open-market purchase of 3,363 shares on 2026-07-27 at $1.49 per share, totaling $5,011. The Form 4/A filed on 2026-08-07 amends the original Form 4 (filed July 29, 2026) solely to correct the transaction code for this purchase; no other transactions were changed.

Key Details

• Transaction date and price: 2026-07-27 — 3,363 shares @ $1.49 each.
• Total value: $5,011.
• Transaction type/code: Open-market purchase (code "P").
• Shares owned after transaction: Not specified in the provided filing.
• Filing status: Original Form 4 was filed July 29, 2026 (timely); this Form 4/A (amendment) was filed August 7, 2026 to correct the transaction code.
• Notable footnote: Amendment only corrects the transaction code; it does not change the reported trade amount or other transactions.

Context

• This was a direct purchase by an executive, not an option exercise or award. Insider purchases are often watched by investors as one data point of insider sentiment, but the trade size here (~$5k) is relatively small and may be routine.